A very promising new antibiotic just started clinical trials
Researchers from ENABLE are hopeful about apramycin because it has passed the stage at which most potential antibiotics fail.
Site Search
Site Search
Displaying results 311 - 320 of 893
Why it’s so hard to make new antibiotics
There’s no lack of chemicals that can kill bacteria. One of the main reasons there have been so few new antibiotics developed in recent decades – apart from a poor return on investment – is that researchers have run out of ideas on how to outwit the protective mechanisms of Gram ...
For small companies, IMI projects can help tap into new markets
CEO of TRISTAN project partner tells IMI about the opportunities that can open up as a result of getting involved in an IMI project. Karin von Wachenfeldt, Ph. D. is the CEO of Truly Labs, a Swedish SME that carries out preclinical research. Tell us about your company: Truly Labs ...
New antibiotics won’t stop antimicrobial resistance. Luckily, there are other things we can try
Vaccines could offer hope - but who to vaccinate, and against what, has no clear answer yet. By Pierre Meulien, Director, IMI
Focus: Antimicrobial resistance
Antimicrobial resistance is becoming one of the defining problems of our time. As bacteria become resistant to the drugs that are supposed to kill them, scientists, policy makers and the pharma industry are looking at different ways to fix the problem before it’s too late. IMI ...
New IMI project puts immune cells in the spotlight
EUR 27 million Immune-Image project will advance the use of imaging technologies to track immune cells. Immunotherapies, which harness the immune system to fight disease, are revolutionising the treatment of many cancers and inflammatory diseases. However, while these innovative ...
Trial of second Ebola vaccine to start in Democratic Republic of the Congo
The trial of the two-dose Ebola vaccine regimen aims to help tackle the current outbreak and strengthen future Ebola epidemic preparedness. An international consortium will soon start a large-scale clinical trial of an Ebola vaccine regimen in the Democratic Republic of the Congo ...
Meet IMI at BIO-Europe 2019
In two weeks’ time, IMI will be in Hamburg for BIO-Europe 2019, which runs from 11 to 13 November. A highlight for IMI will be a session on the morning of 12 November on EU support for small and medium-sized enterprises (SMEs). Among the speakers is IMI’s Magali Poinot, who will ...
IMI at BIO-Europe 2019
IMI teamed up with the European Commission to take part in BIO-Europe 2019 , which was held in Hamburg, Germany, on 11 to 13 November 2019. In addition to a session on funding opportunities for small and medium-sized enterprises (SMEs), we had a stand at the exhibition. Session ...